You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

23 search results for: disease background

New Perspectives in Understanding the Pathophysiology of Atopic Dermatitis in Children - Expert Interview
expert video

New Perspectives in Understanding the Pathophysiology of Atopic Dermatitis in Children - Expert Interview

Dermatology
Watch ADVENT now: Dermatologist Stephan Weidinger explores the pathophysiology and current unmet needs in pediatric atopic dermatitis
View more
Practical Considerations for the Management of Children With Moderate-to-severe Atopic Dermatitis - Expert Interview
expert video

Practical Considerations for the Management of Children With Moderate-to-severe Atopic Dermatitis - Expert Interview

Dermatology
Watch ADVENT now: Dermatologist Amy Paller discusses unmet needs and therapeutic considerations for pediatric patients with atopic dermatitis
View more
Targeted Therapies for Children With Atopic Dermatitis - Expert Interview
expert video

Targeted Therapies for Children With Atopic Dermatitis - Expert Interview

Dermatology
Dermatologist Elaine Seigfried discusses burden & therapeutic landscape of pediatric atopic dermatitis
View more
Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children - Expert Interview (Copy)
expert video

Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children - Expert Interview (Copy)

Dermatology
Watch ADVENT now: Dermatologist Mark Koh describes the Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children.
View more
Diagnostic Considerations: Coexistence, and Distinctions of AD & PN
expert video

Diagnostic Considerations: Coexistence, and Distinctions of AD & PN

Dermatology
Dr. Mark Tang talks about the coexistence of AD and PN and considerations for choosing treatment.
View more
AD and PN: Commonalities and Differences – A Case Study
expert video

AD and PN: Commonalities and Differences – A Case Study

Dermatology
Highlights from the WCD 2023 ADVENT symposium, analyzing case studies and linked comorbidities in relation to atopic dermatitis and prurigo nodularis.
View more
Type 2 Inflammation Alters the Structure and Function of the Skin in AD
expert video

Type 2 Inflammation Alters the Structure and Function of the Skin in AD

Dermatology
Highlights from the WCD 2023 ADVENT symposium, analyzing case studies and linked comorbidities in relation to atopic dermatitis and prurigo nodularis.
View more
Explore the Global Burden of Pediatric AD (PEDISTAD)
interactivity

Explore the Global Burden of Pediatric AD (PEDISTAD)

Dermatology
This interactive tool allows you to explore the global burden of AD in pediatric patients <12 years from the PEDISTAD Study.
View more
Effect of Type 2 Inflammation on Skin Barrier Function in AD​
interactivity

Effect of Type 2 Inflammation on Skin Barrier Function in AD​

Dermatology
Gain insights on how type 2 inflammation affects different aspects of skin barrier function – an interactive educational tool.
View more
Normalizing Skin Barrier by Inhibiting IL-4 & IL-13, or IL-13 Alone
expert video

Normalizing Skin Barrier by Inhibiting IL-4 & IL-13, or IL-13 Alone

Dermatology
Dr. Ramien explores how advanced systemic therapies may modify atopic dermatitis pathomechanisms including skin barrier dysfunction, and neuroimmune dysregulation
View more
ADVENT On Air | Getting to Grips With Atopic Hand and Foot Dermatitis: What Is It, and What Does It Mean for Patients?
Podcast

ADVENT On Air | Getting to Grips With Atopic Hand and Foot Dermatitis: What Is It, and What Does It Mean for Patients?

Dermatology
This podcast episode looks at the epidemiology, clinical presentation and classification of atopic dermatitis of the hand and feet and the impact it has on patients' quality of life.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: IndiaChange country/region